124 related articles for article (PubMed ID: 35918254)
1. Pressure-Controlled Intermittent Coronary Sinus Occlusion: A Novel Approach to Improve Microvascular Flow and Reduce Infarct Size in STEMI.
Gibson CM; Ajmi I; von Koenig CL; Turco MA; Stone GW
Cardiovasc Revasc Med; 2022 Dec; 45():9-14. PubMed ID: 35918254
[TBL] [Abstract][Full Text] [Related]
2. Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
Scarsini R; Terentes-Printzios D; Shanmuganathan M; Kotronias RA; Borlotti A; Marin F; Langrish J; Lucking A; Ribichini F; ; Kharbanda R; Ferreira VM; Channon KM; De Maria GL; Banning AP
Catheter Cardiovasc Interv; 2022 Feb; 99(2):329-339. PubMed ID: 34051133
[TBL] [Abstract][Full Text] [Related]
3. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI-PICSO study).
De Maria GL; Alkhalil M; Borlotti A; Wolfrum M; Gaughran L; Dall'Armellina E; Langrish JP; Lucking AJ; Choudhury RP; Kharbanda RK; Channon KM; Banning AP
EuroIntervention; 2018 Jun; 14(3):e352-e359. PubMed ID: 29792403
[TBL] [Abstract][Full Text] [Related]
4. A novel therapy in microvascular obstruction in ST-elevation myocardial infarction: pressure-controlled intermittent coronary sinus occlusion therapy.
Sehatbakhsh S; Mignatti A; Murthy S; Latib A
Future Cardiol; 2023 Sep; 19(12):615-623. PubMed ID: 37933690
[TBL] [Abstract][Full Text] [Related]
5. First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries.
Pappalardo F; Ancona MB; Giannini F; Regazzoli D; Mangieri A; Montorfano M; De Bonis M; Alfieri O; Zangrillo A; Scandroglio AM; Colombo A; Latib A
Int J Cardiol; 2017 Aug; 241():138-141. PubMed ID: 28501350
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study.
Egred M; Bagnall A; Spyridopoulos I; Purcell IF; Das R; Palmer N; Grech ED; Jain A; Stone GW; Nijveldt R; McAndrew T; Zaman A
Int J Cardiol Heart Vasc; 2020 Jun; 28():100526. PubMed ID: 32435689
[TBL] [Abstract][Full Text] [Related]
7. Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study.
van de Hoef TP; Nijveldt R; van der Ent M; Neunteufl T; Meuwissen M; Khattab A; Berger R; Kuijt WJ; Wykrzykowska J; Tijssen JG; van Rossum AC; Stone GW; Piek JJ
EuroIntervention; 2015 May; 11(1):37-44. PubMed ID: 25868741
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary hemodynamic effects of pressure-controlled intermittent coronary sinus occlusion (PICSO): results from the First-In-Man Prepare PICSO Study.
Van de Hoef TP; Nolte F; Delewi R; Henriques JP; Spaan JA; Tijssen JG; Siebes M; Wykrzykowska JJ; Stone GW; Piek JJ
J Interv Cardiol; 2012 Dec; 25(6):549-56. PubMed ID: 22994798
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention.
Rognoni C; Segantin G; Scarsini R; Valgimigli M; Loizzi F; Costa F; Armeni P
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1101-1111. PubMed ID: 37589294
[TBL] [Abstract][Full Text] [Related]
10. PICSO: from myocardial salvage to tissue regeneration.
Mohl W; Gangl C; Jusić A; Aschacher T; De Jonge M; Rattay F
Cardiovasc Revasc Med; 2015; 16(1):36-46. PubMed ID: 25616738
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction.
Aggarwal S; Xie F; High R; Pavlides G; Porter TR
J Am Soc Echocardiogr; 2018 Jun; 31(6):674-682. PubMed ID: 29525249
[TBL] [Abstract][Full Text] [Related]
13. The role of myocardial work in evaluating coronary microcirculation of STEMI patients after percutaneous coronary intervention.
Ruizhong L; Yanhong L; Fei W; Yushi W; Yuqiong L
Echocardiography; 2021 Dec; 38(12):2060-2068. PubMed ID: 34841596
[TBL] [Abstract][Full Text] [Related]
14. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Shiono Y; Kubo T; Tanaka A; Tanimoto T; Ota S; Ino Y; Aoki H; Ozaki Y; Orii M; Shimamura K; Ishibashi K; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T
JACC Cardiovasc Interv; 2013 Aug; 6(8):847-53. PubMed ID: 23871509
[TBL] [Abstract][Full Text] [Related]
15. Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial.
Kapur NK; Kim RJ; Moses JW; Stone GW; Udelson JE; Ben-Yehuda O; Redfors B; Issever MO; Josephy N; Polak SJ; O'Neill WW
Am Heart J; 2022 Dec; 254():122-132. PubMed ID: 36058253
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial.
Costa JR; Abizaid A; Dudek D; Silber S; Leon MB; Stone GW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):184-90. PubMed ID: 23008177
[TBL] [Abstract][Full Text] [Related]
18. Distal protection device aggravated microvascular obstruction evaluated by cardiac MR after primary percutaneous intervention for ST-elevation myocardial infarction.
Yoon CH; Chung WY; Suh JW; Cho YS; Youn TJ; Chun EJ; Choi SI; Chae IH; Choi DJ
Int J Cardiol; 2013 Sep; 167(5):2002-7. PubMed ID: 22633663
[TBL] [Abstract][Full Text] [Related]
19. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
de Waha S; Patel MR; Granger CB; Ohman EM; Maehara A; Eitel I; Ben-Yehuda O; Jenkins P; Thiele H; Stone GW
Eur Heart J; 2017 Dec; 38(47):3502-3510. PubMed ID: 29020248
[TBL] [Abstract][Full Text] [Related]
20. Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
Redfors B; Furer A; Selker HP; Thiele H; Patel MR; Chen S; Udelson JE; Ohman EM; Eitel I; Granger CB; Maehara A; Kirtane AJ; Généreux P; Jenkins PL; Ben-Yehuda O; Stone GW
J Am Coll Cardiol; 2020 Apr; 75(15):1743-1754. PubMed ID: 32299585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
